Not yet recruiting NCT05626465
Biomarker-s of Abusive Head Trauma by Proteomics
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Blood test.
- Who it may be relevant to
- Registry conditions: Abuse, Child, Protein Disorder, Blood. Basic parameters: up to 2 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France, Switzerland
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Identification of Novel Biomarker-s of Abusive Head Trauma on Serum by Proteomics
Overview
The aim of our study is to highlight biomarker-s of Abusive Head Trauma by proteomics analyses on the serum of child victims of abuse.
Interventions
- Other Blood test
Proteomic analyses on serum
Primary outcome measures
- Highlight novel biomarker-s of AHT [Time frame: Hospital admission to discharge (up to 3 days)]
Eligibility criteria
Inclusion criteria
- Age : 0-2 y.o
- Medical consultation for malaise, seizure (without fever), loss of consciousness, traumatic bain injury, or cranioplasty
- Blood test during medical care
- Accepted informed consent
Exclusion criteria
- Refused informed consent
- For control groups : medical history of child abuse
- For AHT group : rare metabolic disease (Menkes, etc..)
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Case-control
Study locations
France · 1 center
- Ginhoux Thiphanie — Lyon
Switzerland · 1 center
- Wiskott Kim — Geneva
Identifiers
NCT: NCT05626465 · 2021-01971